fashion -WSS

fashion

author：fashion 2025-09-27 12:48:04 - browse：1

Monica Bertagnolli -- Health Policy coverage from STAT — Dr. Monica Bertagnolli speaks during a visit from first lady Jill Biden to the University of California San Francisco Helen Diller Family Comprehensive Cancer Center in San Francisco, Friday, Oct. 7, 2022. (AP Photo/Jeff Chiu, Pool) Jeff Chiu/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will hold a confirmation hearing next month for Monica Bertagnolli, President Biden’s nominee to run the National Institutes of Health, he said Friday.

Sanders, whose health committee oversees the confirmation of the NIH nominee, had refused to hold a hearing on Bertagnolli until the Biden administration promised more drug pricing reform.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care.

Please enter a valid email address. Privacy Policy

HHS announced Friday a deal with Regeneron on the development of the Covid-19 monoclonal antibody. That deal seems to have satisfied Sanders’ demands, though Sanders said the administration must add reasonable pricing provisions to all drugs developed with the help of government funding.

“I welcome the Biden Administration’s announcement today that if Regeneron, through a $326 million contract recently signed with HHS, successfully develops a next generation monoclonal antibody for Covid-19 prevention, the list price of this drug must be equal to or lower than the price in other major countries,” Sanders said in a release.

Sen. Elizabeth Warren (D-Mass.) also had withheld support for Bertagnolli’s nomination until Bertagnolli agreed to Warren’s ethics demands. Bertagnolli agreed to not join the pharmaceutical industry or accept payment from the drug industry, until at least four years after leaving her government position.

Previous article： How to save PrEP access — and even expand it
Next article： Slovenia has suffered its worst

hotspot

WSS

Male and female sex labels in research insufficient, scientists say

Change Healthcare outage fallout shows need for new oversight

Paxlovid rebound happens. Why and to whom are still a mystery

Boston's new lab space is opening empty

'Brian's Song' at 50 still offers lessons about cancer for today

Pushing for an NIH office for post

hotspot

fashion

Sign up for D.C. Diagnosis

focus

Psychedelics group wrestles with new pharma identity

John Green on his newest strategy for fighting tuberculosis

Bright Health sells Medicare Advantage business to Molina

Doctors are clamoring for more clarity on Paxlovid prescribing

Psychedelics group wrestles with new pharma identity

Doctors push to include dialysis machines in emergency stockpile

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Medicare proposal to cover medical devices draws a mixed reaction

Failure, not just success, should guide future doctors

hotspot

Google's generative AI to analyze medical images — and talk to docs

EPA limits use of carcinogenic gas for sterilizing medical devices

Kansas bar where gunfire wounded 9 last month closes permanently

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Why depression after traumatic brain injury is distinct

President Biden's budget: Here's what you might have missed

Wikipedia

hotspot

hotspot

leisure time